Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sands China Ltd. M&A Activity 2021

Mar 15, 2021

50273_rns_2021-03-15_cb9b6811-55cb-4adb-8efa-394a9cbde7f0.pdf

M&A Activity

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [111 x 94] intentionally omitted <==

Asia Pacific Silk Road Investment Company Limited 亞太絲路投資有限公司

(Incorporated in Bermuda with limited liability)

(Stock Code: 767)

VOLUNTARY ANNOUNCEMENT

INVESTMENT COOPERATION FRAMEWORK AGREEMENT

This announcement is made by Asia Pacific Silk Road Investment Company Limited (the ‘‘Company’’) on a voluntary basis.

The board (the ‘‘Board’’) of directors (the ‘‘Directors’’) of the Company is pleased to announce that on 14 March 2021, the Company entered into an investment cooperation framework agreement with Hubei Mailyard Share Co., Ltd. (湖北美爾雅股份有限公司) (‘‘Mailyard’’), pursuant to which, both parties will establish a joint venture company in Xiantao City, Hubei Province.

Upon establishment, the joint venture company will focus on commencing advanced medical services such as cancer prevention and early screening, longevity medical examination and cell management, distributing longevity dietary supplements, and providing longevity management services and longevity solutions and other businesses.

EXCLUSIVITY TERM

Within 90 days from the date of entering into this agreement by both parties conducting project cooperation, the Company shall not negotiate similar investment cooperation, merger and acquisition transactions with other investors.

– 1 –

INFORMATION ON MAILYARD

Mailyard is a joint stock company listed on the Shanghai Stock Exchange (Stock Short Name: ‘‘Mailyard’’ and Stock Code: 600107). Mailyard has made an asset restructuring announcement on 10 July 2020, and is planning for strategic transformation, making full layout in the healthcare industry, engaging in the consultation, operation, research and development of the health services industry. Its actual holding company is Zhongzhi Enterprise Group Co., Ltd. (中植企業集團有限公司) (‘‘Zhongzhi Group’’). Zhongzhi Group is a leading asset management company in China, with its main businesses covering investment, mergers and acquisitions, asset management and industrial funds.

REASONS FOR AND BENEFITS OF ESTABLISHMENT OF JOINT VENTURE COMPANY

Mailyard and Zhongzhi Group own various holding companies with many closely connected domestic high-end group resources with huge demand for advanced medical treatment mainly relating to longevity science. The establishment of a joint venture company will bring long-term, sustainable and stable revenue growth to the Group.

Shareholders and potential investors of the Company should note that the framework agreement may or may not materialise. Shareholders and potential investors of the Company are reminded to exercise caution when dealing in the securities of the Company.

By order of the Board Asia Pacific Silk Road Investment Company Limited Yan Li Chairman

Hong Kong, 15 March 2021

As at the date of this announcement, the Directors are:

Executive Directors Independent non-executive Directors Mr. Yan Li (Chairman) Mr. Chan Wai Dune Mr. Yeung Siu Keung Mr. Mak Ping Leung (alias: Mr. Mak Wah Cheung) Ms. Cao Xie Qiong Mr. To Langa Samuelson

Non-executive Directors

Ms. Yu Yang Ms. Choi Ngai Wah

In the case of any inconsistency, the English text of this announcement shall prevail over the Chinese text.

– 2 –